Referral and ascertainment bias in patients with synchronous and metachronous endometrial malignancy

The purpose of this study was to evaluate the frequency in patients with endometrial cancer of other malignancies and the influence of referral and ascertainment biases on these associations. Analysis of 1,028 local and referred patients who had a hysterectomy for endometrial cancer was based on residence at the time of diagnosis. Altogether, 208 patients had a history of another malignancy, most frequently breast, colon, and ovary. At the time of surgery for endometrial cancer, the prevalence of lymphoma and breast and ovarian cancers was greater than expected although the higher prevalence of lymphoma was limited to referred patients. During followup after hysterectomy, the incidence of lung cancer was lower than expected, whereas the incidence of lymphoma was higher. Breast, colorectal, and bladder cancers were more common than expected although this finding was limited to local patients. We concluded that results of epidemiologic studies from tertiary care centers may be misleading if they do not account for referral and ascertainment biases.

Ascertainment bias; Endometrial cancer; Epidemiology; Multiple malignancies; Referral bias.

[1] Jemal A., Siegel R., Ward E., Murray T., Xu J., Thun M.J.: “Cancer statistics”. C.A. Cancer J. Clin., 2007, 57, 43.

[2] Aarnio M., Mecklin J.P., Aaltonen L.A., Nystrom-Lahti M., Jarvinen H.J.: “Life-time risk of different cancers in hereditary nonpolyposis colorectal cancer (HNPCC) syndrome”. Int. J. Cancer, 1995, 64, 430.

[3] Annegers J.F., Malkasian G.D. Jr.: “Patterns of other neoplasia in patients with endometrial carcinoma”. Cancer, 1981, 48, 856.

[4] Axelrod J.H., Fruchter R., Boyce J.G.: “Multiple primaries among gynecologic malignancies”. Gynecol. Oncol., 1984, 18, 359.

[5] Herrinton L.J., Voigt L.F., Weiss N.S., Beresford S.A., Wingo P.A.: “Risk factors for synchronous primary endometrial and ovarian cancers”. Ann. Epidemiol., 2001, 11, 529.

[6] Re A., Taylor T.H., DiSaia P.J., Anton-Culver H.: “Risk for breast and colorectal cancers subsequent to cancer of the endometrium in a population-based case series”. Gynecol. Oncol., 1997, 66, 255.

[7] Hemminki K., Aaltonen L., Li X.: “Subsequent primary malignancies after endometrial carcinoma and ovarian carcinoma”. Cancer, 2003, 97, 2432.

[8] Malkasian G.D., Annegers J.F.: “Endometrial carcinoma comparison of Olmsted County and Mayo Clinic referral patients”. Mayo Clin. Proc., 1980, 55, 614.

[9] Mariani A., Dowdy S.C., Keeney G.L., Long H.J., Lesnick T.G., Podratz K.C.: “High-risk endometrial cancer subgroups: candidates for target-based adjuvant therapy”. Gynecol. Oncol., 2004, 95, 120.

[10] Mariani A., Dowdy S.C., Keeney G.L., Haddock M.G., Lesnick T. G., Podratz K.C.: “Predictors of vaginal relapse in stage I endometrial cancer”. Gynecol. Oncol., 2005, 97, 820.

[11] Melton L.J. 3rd.: “The threat to medical-records research”. N. Engl. J. Med., 1997, 337, 1466.

[12] Creasman W.T., Odicino F., Maisonneuve P., Beller U., Benedet J.L., Heintz A.P. et al.: “Carcinoma of the corpus uteri”. J. Epidemiol. Biostat., 2001, 6, 47.

[13] Scully R.E., Bonfiglio T.A., Kurman R.J., Silverberg S.G., Wilkinson E.J. (eds.): “World Health Organization International Histological Classification of Tumours: Histological Typing of Female Genital Tract Tumours”. 2nd edition, Berlin, Springer-Verlag, c1994, 13.

[14] Ulbright T.M., Roth L.M.: “Metastatic and independent cancers of the endometrium and ovary: a clinicopathologic study of 34 cases”. Hum. Pathol., 1985, 16, 28.

[15] SEER Cancer Statistics Review 1975-2000 [Internet] [cited 2004 May 10]. Available from: http://seer.cancer.gov.

[16] Bergstralh E., Offord K.P., Kosanke J.J., Augustine G.: “Technical report series no. 31, PERSONYRS: a SAS procedure for person year analyses”. Rochester (MN), Department of Health Sciences Research, 1986.

[17] Maruyama A., Miyamoto S., Saito T., Kondo H., Baba H., Tsukamoto N.: “Clinicopathologic and familial characteristics of endometrial carcinoma with multiple primary carcinomas in relation to the loss of protein expression of MSH2 and MLH1”. Cancer, 2001, 91, 2056.

[18] Maximov S.J., Bokhman J.B.: “Syndrome of primary multiple endometrial, breast, ovarian and colon adenocarcinoma”. Eur. J. Gynaecol. Oncol., 1993, 14, 109.

[19] Santos M.C., Gardner B., Feldman J.: “Analysis of multiple primary cancers in a single institution”. J. Surg. Oncol., 1994, 55, 95.

[20] Schwartz Z., Ohel G., Birkenfeld A., Anteby S.O., Schenker J.G.: “Second primary malignancy in endometrial carcinoma patients”. Gynecol. Oncol., 1985, 22, 40.

[21] Thomas L., Doyle L.A., Edelman M.J.: “Lung cancer in women: emerging differences in epidemiology, biology, and therapy”. Chest, 2005, 128, 370.

[22] Viswanathan A.N., Feskanich D., De Vivo I., Hunter D.J., Barbieri R.L., Rosner B. et al.: “Smoking and the risk of endometrial cancer: results from the Nurses’ Health Study”. Int. J. Cancer, 2005, 114, 996.

[23] Beasley M.B., Brambilla E., Travis W.D.: “The 2004 World Health Organization classification of lung tumors”. Semin. Roentgenol., 2005, 40, 90.

[24] Liauw S.L., Sylvester J.E., Morris C.G., Blasko J.C., Grimm P.D.: “Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up”. Int. J. Radiat. Oncol. Biol. Phys., 2006, 66, 669.